Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
5
×
boston top stories
eli lilly
life sciences
national blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
deals
fda
johnson & johnson
startups
abbvie
aduro biotech
agenus
alzheimer's disease
biogen
What
companies
5
×
drug
5
×
bio
new
roundup
approval
fda
nash
news
price
therapies
year
alzheimer’s
approved
arguments
big
biogen’s
biopharmaceutical
biotech
black
cancer
class
clinic
commercialized
competitors
convo
decades
diamond
different
digital
disease
drugs
earlier
eluded
epidemic
fail
failures
fatty
frenzied
gene
Language
unset
Current search:
biotech
×
companies
×
drug
×
" boston blog main "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More